Balyasny Asset Management »

Castle Biosciences shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $327k 15k 22.15
2020-12-31 $385k 5.7k 67.24

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Pioneer Natural Resources Put Option (PXD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
JPMorgan Chase & Co. Call Option (JPM)
Hess Call Option (HES)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Asml Holding N V N Y Registry Shs Call Option (ASML)

View all positions for Balyasny Asset Management

Top funds holding Castle Biosciences

BlackRock
Daniel D. Thurber
Granahan Investment Management
Principal Financial Group
Vanguard Group
Bellevue Group
Portolan Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Soleus Capital Management
Citadel Advisors
Morgan Stanley
State Street Corporation
Geode Capital Management
Palisade Capital Management

View all funds holding Castle Biosciences